Showing 1 - 13 results of 13 for search 'Victor H.F. Lee', query time: 0.08s Refine Results
  1. 1
    Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

    Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis by Bin Zou, Victor H. F. Lee, Hong Yan

    Published 2018-03-01
    Get full text
    Article
  2. 2
    Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.

    Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments. by Debby D Wang, Lichun Ma, Maria P Wong, Victor H F Lee, Hong Yan

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations

    Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations by Bin Zou, Victor H. F. Lee, Lijiang Chen, Lichun Ma, Debby D. Wang, Hong Yan

    Published 2017-07-01
    Get full text
    Article
  4. 4
    Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer

    Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer by Shing Fung Lee, Horace C. W. Choi, Sik Kwan Chan, Ka On Lam, Ka On Lam, Victor H. F. Lee, Victor H. F. Lee, Irene O. L. Wong, Chi Leung Chiang, Chi Leung Chiang, Chi Leung Chiang

    Published 2021-05-01
    Get full text
    Article
  5. 5
    A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

    A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening by Chi C. Tong, Ching W. Lam, Ka O. Lam, Victor H. F. Lee, Mai-Yee Luk

    Published 2018-07-01
    Get full text
    Article
  6. 6
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-base... by Keith W. H. Chiu, Ka-On Lam, H. An, Gavin T. C. Cheung, Johnny K. S. Lau, Tim-Shing Choy, Victor H. F. Lee

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma

    Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma by Alan W.L. Mui, Anne W.M. Lee, W.T. Ng, Victor H.F. Lee, Varut Vardhanabhuti, Shei S.Y. Man, Daniel T.T. Chua, X.Y. Guan

    Published 2022-10-01
    Get full text
    Article
  8. 8
    Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging

    Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging by Alan W.L. Mui, Anne W.M. Lee, Wai-Tong Ng, Victor H.F. Lee, Varut Vardhanabhuti, Shei-Yee Man, Daniel T.T. Chua, Xin-Yuan Guan

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.

    Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma. by Victor H F Lee, Anthony W I Lo, Chun-Yin Leung, Wai-Hung Shek, Dora L W Kwong, Ka-On Lam, Chi-Chung Tong, Chun-Kin Sze, To-Wai Leung

    Published 2016-01-01
    Get full text
    Article
  10. 10
    Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

    Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study by Wei Kang, Jessica J. P. Shami, Vincent K. C. Yan, Xuxiao Ye, Joseph E. Blais, Xue Li, Victor H. F. Lee, Celine S. L. Chui, Francisco T. T. Lai, Eric Y. F. Wan, Carlos K. H. Wong, Ian C. K. Wong, Esther W. Chan

    Published 2022-05-01
    Get full text
    Article
  11. 11
    Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis

    Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis by Wei Kang, Kuan Peng, Vincent K.C. Yan, Daoud Al-Badriyeh, Shing Fung Lee, Hei Hang Edmund Yiu, Yue Wei, Silvia T. H. Li, Xuxiao Ye, Aya El Helali, Ka On Lam, Victor H. F. Lee, Ian C. K. Wong, Esther W. Chan

    Published 2024-12-01
    Get full text
    Article
  12. 12
    Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis

    Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis by Wei Kang, Caige Huang, Vincent K. C. Yan, Yue Wei, Jessica J. P. Shami, Silvia T. H. Li, Yu Yang, Xuxiao Ye, Junhan Tang, Shing Fung Lee, Victor H. F. Lee, Stephen L. Chan, Aya El Helali, Ka On Lam, Roger K. C. Ngan, Ian C. K. Wong, Esther W. Chan

    Published 2024-07-01
    Get full text
    Article
  13. 13
    Developing a named entity framework for thyroid cancer staging and risk level classification using large language models

    Developing a named entity framework for thyroid cancer staging and risk level classification using large language models by Matrix M. H. Fung, Eric H. M. Tang, Tingting Wu, Yan Luk, Ivan C. H. Au, Xiaodong Liu, Victor H. F. Lee, Chun Ka Wong, Zhili Wei, Wing Yiu Cheng, Isaac C. Y. Tai, Joshua W. K. Ho, Jason W. H. Wong, Brian H. H. Lang, Kathy S. M. Leung, Zoie S. Y. Wong, Joseph T. Wu, Carlos K. H. Wong

    Published 2025-03-01
    Get full text
    Article

Search Tools: